# OnCo record rejuv-tx-endocrine-and-cardiometabolic (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-tx-endocrine-and-cardiometabolic/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-tx-endocrine-and-cardiometabolic" ;
  schema:name "Hormones, metabolism and the heart after transplant"@en ;
  schema:alternateName "endocrine late effects after HSCT"@en, "metabolic syndrome after transplant"@en, "cardiovascular disease after HCT"@en, "sarcopenic obesity after transplant"@en ;
  schema:description "Transplant conditioning can leave the thyroid underactive, the ovaries or testes not working, and the handling of sugar and fat altered in a way that raises heart risk years later. Much of this is treatable with ordinary medicine, and the familiar things about weight, exercise and smoking matter more here than usual, not less."@en ;
  schema:url <https://onco.cc/technologies/rejuv-tx-endocrine-and-cardiometabolic/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hypothyroidism> ;
  schema:citation <https://doi.org/10.1016/j.bbmt.2014.02.012>, <https://doi.org/10.1182/bloodadvances.2018019117>, <https://doi.org/10.1016/j.bbmt.2016.08.019>, <https://doi.org/10.1016/j.jtct.2023.10.026>, <https://doi.org/10.1016/j.bbmt.2011.12.519>, <https://doi.org/10.3324/haematol.2016.150250> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "transplant", "late-effects", "endocrine", "heart" ;
  onco:related <https://onco.cc/technologies/rejuv-tx-late-effects-overview/>, <https://onco.cc/technologies/rejuv-tx-bone-eyes-kidneys-lungs/>, <https://onco.cc/technologies/rejuv-tx-fertility-and-growth/>, <https://onco.cc/technologies/menopause-after-cancer-treatment/>, <https://onco.cc/technologies/testosterone-after-cancer-treatment/>, <https://onco.cc/technologies/exercise-prescription-after-cancer/>, <https://onco.cc/technologies/cardiotoxicity-surveillance-recovery/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/technologies/total-body-irradiation/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:terms <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/conditioning-regimen/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> .